Brokerages predict that Healthequity Inc (NASDAQ:HQY) will post $85.38 million in sales for the current quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Healthequity’s earnings. The lowest sales estimate is $83.90 million and the highest is $86.69 million. Healthequity posted sales of $71.07 million during the same quarter last year, which would indicate a positive year over year growth rate of 20.1%. The company is expected to issue its next quarterly earnings report after the market closes on Tuesday, September 3rd.

On average, analysts expect that Healthequity will report full-year sales of $343.27 million for the current financial year, with estimates ranging from $342.30 million to $344.38 million. For the next financial year, analysts expect that the business will report sales of $391.91 million, with estimates ranging from $385.19 million to $398.50 million. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover Healthequity.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, June 4th. The company reported $0.36 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.25 by $0.11. The firm had revenue of $87.05 million during the quarter, compared to analysts’ expectations of $83.98 million. Healthequity had a return on equity of 14.17% and a net margin of 30.60%.

Several equities analysts recently weighed in on the company. JPMorgan Chase & Co. set a $80.00 price target on Healthequity and gave the company an “overweight” rating in a research note on Wednesday, June 5th. Zacks Investment Research upgraded Healthequity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, May 21st. BidaskClub lowered Healthequity from a “buy” rating to a “hold” rating in a research note on Wednesday, August 14th. Raymond James boosted their price objective on Healthequity from $85.00 to $90.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Finally, Citigroup reiterated a “buy” rating on shares of Healthequity in a research note on Friday, June 28th. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $87.92.

Shares of HQY stock traded up $0.61 on Friday, hitting $61.30. The company had a trading volume of 30,703 shares, compared to its average volume of 796,732. The firm has a market cap of $3.94 billion, a P/E ratio of 64.54, a price-to-earnings-growth ratio of 3.08 and a beta of 1.47. The company has a 50-day moving average price of $72.40 and a 200-day moving average price of $72.19. The company has a quick ratio of 15.59, a current ratio of 15.60 and a debt-to-equity ratio of 0.07. Healthequity has a twelve month low of $50.29 and a twelve month high of $101.58.

In other Healthequity news, VP Angelique Christine Hill sold 9,500 shares of the stock in a transaction on Friday, July 12th. The shares were sold at an average price of $71.40, for a total value of $678,300.00. Following the completion of the sale, the vice president now directly owns 15,887 shares of the company’s stock, valued at approximately $1,134,331.80. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Jon Kessler purchased 10,000 shares of Healthequity stock in a transaction on Friday, July 12th. The stock was bought at an average cost of $61.00 per share, with a total value of $610,000.00. Following the completion of the acquisition, the chief executive officer now owns 442,410 shares in the company, valued at $26,987,010. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 33,899 shares of company stock valued at $2,508,171. 3.70% of the stock is owned by insiders.

Several large investors have recently added to or reduced their stakes in the company. Meeder Asset Management Inc. acquired a new stake in shares of Healthequity during the 2nd quarter worth about $25,000. BerganKDV Wealth Management LLC acquired a new stake in shares of Healthequity during the 2nd quarter worth about $26,000. FTB Advisors Inc. acquired a new stake in shares of Healthequity during the 2nd quarter worth about $27,000. Griffin Asset Management Inc. acquired a new stake in shares of Healthequity during the 2nd quarter worth about $29,000. Finally, Manchester Capital Management LLC acquired a new stake in shares of Healthequity during the 1st quarter worth about $36,000. 95.54% of the stock is owned by institutional investors.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading: CD Ladder

Get a free copy of the Zacks research report on Healthequity (HQY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.